Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
US8450326B2 · kind B2 · utility
0Cited by
5References
57Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2009 |
| Grant date | May 28, 2013 |
| Priority date | — |
| Expiry date | Nov 26, 2030 |
Classification
- Technology area (CPC —)General
Abstract
Multiheteroaryl compounds, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical use in the prevention and treatment of prostaglandin D2 mediated diseases and conditions that may be modulated by the inhibition of hematopoietic prostaglandin D synthase (H-PGDS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.